Cvs Health (CVS) Short term Debt (2009 - 2026)

Cvs Health has reported Short term Debt for 18 years, with the latest figure at $2.6 billion in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt fell 41.51% year-over-year to $2.6 billion; the trailing twelve-month figure through Mar 2026 stood at $2.6 billion (down 41.51% YoY), and the FY2025 full-year result was $4.1 billion, up 12.25% from the prior year.
• Short term Debt for Q1 2026 stood at $2.6 billion, down from $4.1 billion in the prior quarter.
• The five-year high for Short term Debt was $6.2 billion in Q2 2025, with the low at $200.0 million in Q4 2023.
• Historically, Short term Debt has averaged $2.6 billion across 5 years, with a median of $2.4 billion in 2023.
• Annual changes were most pronounced in 2022 — Short term Debt soared 6598.33% — and 2023, when it plunged 88.75%.
• Cvs Health's Short term Debt stood at $1.8 billion in 2022, then sank by 88.75% to $200.0 million in 2023, then surged by 1712.0% to $3.6 billion in 2024, then climbed by 12.25% to $4.1 billion in 2025, then sank by 36.58% to $2.6 billion in 2026.
• The last three Short term Debt figures came in at $2.6 billion (Q1 2026), $4.1 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.